Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 187,163 shares at $17.01 ($3.2M) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Scheduled sale ($3.2M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.97 | 51,560 | $875K | 27.5% |
| 2 | $16.97 | 56,323 | $956K | 30.1% |
| 3 | $16.97 | 61,563 | $1.0M | 32.9% |
| 4 | $17.01 | 17,717 | $301K | 9.5% |
| Total | $16.97 avg | 187,163 | $3.2M | 100% |
| Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |
| RLAY | SELL | 2026-05-14 | $228K | — | Filing → |